Abstract | OBJECTIVE: A randomized, multicenter, controlled double-blind trial was performed in women with cyclic breast pain ( mastalgia) associated with fibrocystic breast changes (FBCs) to determine whether a nutritional formula reduced breast pain and/or nodularity. STUDY DESIGN: Women were randomized to receive a specifically designed liquid formulation (n = 93) (1 g gamma-linolenic acid [GLA], 750 μg iodine, and 70 μg selenium) or control formula (n = 95) (without GLA, iodine, and selenium) daily for three cycles. Women recorded breast pain, medications, and menstrual signs daily using interactive voice-response system. Nodularity was determined by physical breast examination. RESULTS:
Breast pain scores decreased similarly in the experimental (-32.2%) and control (-33.1%) groups (p = 0.64). Nodularity was reduced in the experimental, but not the control group (p = 0.03). Among women who continued pain medication, the amount was reduced in the experimental group relative to controls (p = 0.02). CONCLUSION: Women with FBC using the formula containing GLA, iodine, and selenium experienced reduced nodularity and in those women who took over-the-counter breast pain medication, a decrease in the quantity of pain medication was observed.
|
Authors | Robert E Mansel, Tapas Das, Geraldine E Baggs, Michael J Noss, William P Jennings, Jay Cohen, David Portman, Mario Cohen, Anne Coble Voss |
Journal | Journal of women's health (2002)
(J Womens Health (Larchmt))
Vol. 27
Issue 3
Pg. 333-340
(03 2018)
ISSN: 1931-843X [Electronic] United States |
PMID | 29237134
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- gamma-Linolenic Acid
- Iodine
- Selenium
|
Topics |
- Adolescent
- Adult
- Breast
(physiopathology)
- Breast Diseases
(therapy)
- Double-Blind Method
- Female
- Humans
- Iodine
(administration & dosage)
- Mastodynia
(pathology, therapy)
- Menstrual Cycle
(physiology)
- Middle Aged
- Pain
(drug therapy)
- Pain Measurement
- Prospective Studies
- Selenium
(administration & dosage)
- Treatment Outcome
- gamma-Linolenic Acid
(administration & dosage)
|